COVID-19 in pregnant women after assisted reproductive technologies receiving low molecular weight heparins
Obstetrics, Gynecology and Reproduction
; 15(3):225-227, 2021.
Article
in Russian
| EMBASE | ID: covidwho-1344587
ABSTRACT
We have accumulated my own experience of management pregnant women with COVID-19 after assisted reproductive technologies (ART) receiving low molecular weight heparins (LMWH). All women suffered COVID-19 in mild form without respiratory failure and gave birth to healthy children. Our observations correspond to the data of world literature. Therefore, we want to draw the attention of the editors and the readers to the positive role of LMWH in the control of COVID-19.
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Observational study
/
Prognostic study
Language:
Russian
Journal:
Obstetrics, Gynecology and Reproduction
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS